Aviva USA has been granted US patent for 'maximization of a hedged investment budget for an index-linked insurance product' by the US Patent and Trademark Office.
The patent involves Aviva’s risk management processes related to the minimum guarantees on its indexed universal life insurance products.
Thomas Godlasky, CEO of Aviva North America, said: The granting of this patent underscores Aviva’s commitment to innovation in the area of product development.
It is truly a testament to the outstanding work being done by Aviva’s product development team. As a company, our primary focus is on providing the best products and services to our customers, and the innovation behind this patent exemplifies that commitment.